AJP - GI Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 288: G1266-G1273, 2005. First published February 3, 2005; doi:10.1152/ajpgi.00444.2004
0193-1857/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/6/G1266    most recent
00444.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimball, E. S.
Right arrow Articles by Wade, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimball, E. S.
Right arrow Articles by Wade, P. R.

NEUROREGULATION AND MOTILITY

Acute colitis induction by oil of mustard results in later development of an IBS-like accelerated upper GI transit in mice

Edward S. Kimball,1 Jeffrey M. Palmer,1 Michael R. D'Andrea,2 Pamela J. Hornby,1 and Paul R. Wade1

1Enterology Research Team and 2Target Validation Team, Johnson & Johnson Pharmaceutical Research and Development, Spring House, Pennsylvania

Submitted 30 September 2004 ; accepted in final form 22 January 2005

Oil of mustard (OM) is a potent neuronal activator that promotes allodynia and hyperalgesia within minutes of application. In this study, OM was used to induce an acute colitis. We also investigated whether intracolonic OM-induced inflammation alters gastrointestinal (GI) function over a longer time frame as a model of postinflammatory irritable bowel syndrome (PI-IBS). Mice given a single administration of 0.5% OM developed a severe colitis that peaked at day 3, was reduced at day 7, and was absent by day 14. At the peak response, there was body weight loss, colon shrinkage, thickening and weight increases, distension of the proximal colon, and diarrhea. Macroscopic inspection of the distal colon revealed a discontinuous pattern of inflammatory damage and occasional transmural ulceration. Histological examination showed loss of epithelium, an inflammatory infiltrate, destruction of mucosal architecture, edema, and loss of circular smooth muscle architecture. OM administration increased transit of a carmine dye bolus from 58% of the total length of the upper GI tract in untreated age-matched controls to as high as 74% when tested at day 28 post-OM. Mice in the latter group demonstrated a significantly more sensitive response to inhibition of upper GI transit by the µ-opioid receptor agonist loperamide compared with normal mice. OM induces a rapid, acute, and transient colitis and, in the longer term, functional changes in motility that are observed when there is no gross inflammation and thereby is a model of functional bowel disorders that mimic aspects of PI-IBS in humans.

small intestine; large intestine; postinflammatory irritable bowel syndrome; irritable bowel syndrome; inflammatory bowel disease



Address for reprint requests and other correspondence: E. S. Kimball, Enterology Research Team, Johnson and Johnson Pharmaceutical, Research and Development, Welsh and McKean Roads, PO Box 776, Spring House, PA, 19477–0776 (E-mail: ekimball{at}prdus.jnj.com)




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
I. M. Carroll, J. M. Andrus, J. M. Bruno-Barcena, T. R. Klaenhammer, H. M. Hassan, and D. S. Threadgill
Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis
Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G729 - G738.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. S. Kimball, C. R. Schneider, N. H. Wallace, and P. J. Hornby
Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium
Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G364 - G371.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.